Dr. Jeremy Perkins
Claim this profileWalter Reed National Military Medical Center
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
15 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Jeremy Perkins is currently running
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
More about Jeremy Perkins
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jeremy Perkins has experience with
- Questionnaire Administration
- Biospecimen Collection
- Imlunestrant
- Tamoxifen
- Anastrozole
- Letrozole
Breakdown of trials Jeremy Perkins has run
Breast Cancer
Cancer
Tumors
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy Perkins specialize in?
Jeremy Perkins focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Jeremy Perkins currently recruiting for clinical trials?
Yes, Jeremy Perkins is currently recruiting for 4 clinical trials in Bethesda Maryland. If you're interested in participating, you should apply.
Are there any treatments that Jeremy Perkins has studied deeply?
Yes, Jeremy Perkins has studied treatments such as Questionnaire Administration, Biospecimen Collection, Imlunestrant.
What is the best way to schedule an appointment with Jeremy Perkins?
Apply for one of the trials that Jeremy Perkins is conducting.
What is the office address of Jeremy Perkins?
The office of Jeremy Perkins is located at: Walter Reed National Military Medical Center, Bethesda, Maryland 20889 United States. This is the address for their practice at the Walter Reed National Military Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.